Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Top Technology Executives Recognized at the 2025 HoustonCIO ORBIE Awards
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KinderCare Learning Companies, Inc. - KLC
-
Joseph Schnaier Launches $1,000 National Scholarship to Support and Cultivate Future Finance Leaders in U.S. Undergraduate Programs
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pony AI Inc. - PONY
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO
-
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
-
Willms and Associates Named Rockford Mutual 2024 Agency of the Year
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of 3D Systems Corporation - DDD
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Endeavour Silver Corp. - EXK
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
-
Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Ann
-
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northrop Grumman Corporation – NOC
-
Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets
-
Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025
-
DTE Completes Construction on Pine River Solar Park
-
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
-
SAG HOLDINGS LIMITED CHANGE ITS NAME TO INNEOVA HOLDINGS LIMITED
-
Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit
-
Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025
-
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
-
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
-
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
-
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Open Lending Corp. - LPRO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altria Group, Inc. - MO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Greenbrier Companies, Inc. - GBX
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Watsco, Inc. - WSO
-
American Rebel CEO Andy Ross Harnesses Media Appearance on NBC-TV West Palm Beach Affiliate to Amplify Growth Strategy, Propel Brand Expansion and Launch American Rebel Light Beer in Florida
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strategy Incorporated (f/k/a MicroStrategy Incorporated) - MSTR
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Movado Group, Inc. - MOV
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines – ZBIO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TechTarget, Inc. – TTGT
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Uber Technologies, Inc. – UBER
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CarMax, Inc. - KMX
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kyndryl Holdings, Inc. - KD
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agilysys, Inc. - AGYS
-
Nestlé appoints Jeff Hamilton as CEO Zone Americas, Steve Presley to retire from the company
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ibotta, Inc of Class Action Lawsuit and Upcoming Deadlines - IBTA
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZBIO
-
Transaction in Own Shares
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
-
Farm Management Canada Celebrates a Year of Partnership, Growth and Impact
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Everus Construction Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - ECG
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bakkt Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - BKKT
-
Fundraising Effectiveness Project Data for Q4 2024 highlights the growing role of high-dollar donors in driving fundraising performance across the sector

